Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): Sexually Transmitted Diseases

Sexually transmitted diseases (STDs) remain a major global health concern with wide-ranging clinical, economic, and humanistic consequences. This chapter explores the integral role of pharmacists in STD prevention and management using an evidence-based approach. Pharmacist-led care improves clinical outcomes through early detection, appropriate pharmacotherapy, adherence support, and patient counseling. Economically, pharmacists help reduce healthcare costs by ensuring medication efficiency, promoting generic use, minimizing treatment failures, and facilitating timely interventions. From a humanistic perspective, pharmacists enhance quality of life by reducing stigma, improving patient knowledge and perceptions, and supporting behavior change through education and empathetic communication. Their accessibility, confidentiality, and community-based presence position them as key players in public health campaigns, vaccination efforts, and referral systems. Despite challenges such as stigma, limited scope of practice, and reimbursement issues, pharmacists offer transformative potential in STD care. Strengthening their role through policy reforms and collaborative models is essential for improving outcomes at the patient and population levels.